BlueCrest Capital Management (UK)’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5.69M Buy
174,862
+100,000
+134% +$3.4M 0.21% 79
2014
Q2
$2.62M Sell
74,862
-202,416
-73% -$6.65M 0.09% 183
2014
Q1
$8.78M Buy
277,278
+106,916
+63% +$2.97M 0.5% 44
2013
Q4
$4.31M Buy
170,362
+133,162
+358% +$3.19M 0.35% 61
2013
Q3
$795K Buy
+37,200
New +$764K 0.04% 241

Other funds holding PTEN

BlueCrest Capital Management (UK)'s PTEN Position: Q3 2014 in Review

BlueCrest Capital Management (UK) increased its Patterson-UTI (PTEN) stake by 134% in Q3 2014, buying an estimated $3.4M and bringing the position to 174,862 shares worth $5.69M. The position accounts for 0.21% of the portfolio, ranked #79.

BlueCrest Capital Management (UK) first reported a position in PTEN in Q3 2013 and has held it in 5 quarters since. The position peaked at $8.78M in Q1 2014. 329 funds tracked by Wall St. Rank hold PTEN as of Q3 2014.

  • BlueCrest Capital Management (UK) held 174,862 shares of Patterson-UTI worth $5.69M as of Q3 2014.
  • BlueCrest Capital Management (UK) bought 100,000 Patterson-UTI shares in Q3 2014, an estimated $3.4M.
  • Patterson-UTI made up 0.21% of BlueCrest Capital Management (UK)'s portfolio in Q3 2014, its #79 holding.
  • BlueCrest Capital Management (UK) first reported a position in Patterson-UTI in Q3 2013 and has held it in 5 quarters since.
  • BlueCrest Capital Management (UK)'s Patterson-UTI position peaked at $8.78M in Q1 2014.
  • 329 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.